Articles dans des revues avec comité de lecture (64)
  1. 61. Heimberg, H., Heremans, Y., Jobin, C., Leemans, R., Darville, M., Cardozo, A. K., & Eizirik, D. L. (2001). Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis. Diabetes (New York, N.Y.), 50(10), 2219-2224.
  2. 62. Cardozo, A. K., Heimberg, H., Heremans, Y., Leeman, R., Kutlu, B., Kruhøffer, M., Ørntoft, T., & Eizirik, D. L. (2001). A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells. The Journal of biological chemistry, 276(52), 48879-48886. doi:10.1074/jbc.M108658200
  3. 63. Cardozo, A. K., Kruhøffer, M., Leeman, R., Orntoft, T. F., & Eizirik, D. L. (2001). Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays. Diabetes (New York, N.Y.), 50(5), 909-920.
  4. 64. Cardozo, A. K., De Meirleir, L., Liebaers, I., & Lissens, W. (2000). Analysis of exonic mutations leading to exon skipping in patients with pyruvate dehydrogenase E1 alpha deficiency. Pediatric research, 48(6), 748-753.
    5.   Communications publiées lors de congrès ou colloques nationaux et internationaux (9)
  5. 1. Veli, O., Hildebrandt, H., Xiao, P., Estornes, Y., Kaya, O., Bertrand, M., Cardozo, A. K., & Peltzer, N. (2023). Ripk1 is dispensable for beta cell survival in diabetes. Diabetologia., 66 (Suppl 1):S1–S536. doi:10.1007/s00125-023-05969-6
  6. 2. Lavis, P., Pingitore, J., Doumont, G., Gabaret, A., Van Simaeys, G., Lacroix, S., Passon, N., Van Heymbeek, C., De Maeseneire, C., Huaux, F., Decaestecker, C., Salmon, I., Cardozo, A. K., Goldman, S., & Bondue, B. (2023). Fibroblast Activation Protein Inhibitor, a Promising Radiotracer inFibrogenesis. American journal of respiratory and critical care medicine,(207), A4704. doi:https://doi.org/10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A4704
  7. 3. Blanc, M., Xiao, P., Gilleron, J., Janona, M., Lacas-Gervais, S., Yvan-Charvet, L., Gual, P., Cardozo, A. K., & Bailly Maître, B. (2022). Bax Inhibitor 1 protects against pancreatic beta cell death and meta- bolic disorders. European Association for the Study of Diabetes, 58th, Stockholm, Sweden, 2022-09-19, Diabetologia, (vol. 65, p. 211) (ISSN: 0012-186X) doi:10.1007/s00125-022-05755-w
  8. 4. Takiishi, T., Xiao, P., Gurzov, E. N., Bertrand, M., & Cardozo, A. K. (2022). Pancreatic beta cells are resistant to RIPK1 kinase-mediated death. Diabetologia,(vol. 65, p. 211). doi:10.1007/s00125-022-05755-w
  9. 5. Vandenbempt, V., Eski, S. E., Brahma, M. K., Li, A., Demine, S., Xiao, P., Cardozo, A. K., Singh, S. P., Mariño, E., Gysemans, C., & Gurzov, E. N. (2022). Single-cell sequencing reveals preserved pancreatic islet cell identity by administration of metabolite-based diet in autoimmune diabetes. Diabetologia, Vol. 65 , 211. doi:10.1007/s00125-022-05755-w
  10. 6. Brahma, M. K., Xiao, P., Popa, M., Vandenbempt, V., Negueruela Escudero, J., Cardozo, A. K., & Gurzov, E. N. (2021). The Nova1-Bim axis in pancreatic beta-cells does not impact glucose homeostasis in obesity and multiple low-dose streptozotocin-induced diabetes. Diabetologia,(64 (Suppl 1):S1–S380). doi:10.1007/s00125-021-05519-y
  11. 7. Xiao, P., Takiishi, T., Moretti Violato, N., Licata, G., Dotta, F., Sebastiani, G., & Cardozo, A. K. (2021). The role of NF-kappa B-inducing kinase (NIK) in beta cell-mediated inflammation in type 1 diabetes. Diabetologia,(64 (Suppl 1):S1–S380). doi:10.1007/s00125-021-05519-y
  12. 8. Xiao, P., Takiishi, T., Moretti Violato, N., Licata, G., Dotta, F., Sebastiani, G., & Cardozo, A. K. (2020). The role of NF-κB-inducing kinase (NIK) in beta cell-mediated inflammation in type 1 diabetes. Diabetologia., 63(Suppl 1):1-485. doi:10.1007/s00125-020-05221-5
    13. << Précédent 1 2 3 4 5 6 7 Suivant >>